• Products
  • Catalogs
  • News & Trends
  • Exhibitions

Aortic valve prosthesis CARBOMEDICS™
titanium

Aortic valve prosthesis - CARBOMEDICS™ - Corcym - titanium
Aortic valve prosthesis - CARBOMEDICS™ - Corcym - titanium
Aortic valve prosthesis - CARBOMEDICS™ - Corcym - titanium - image - 2
Aortic valve prosthesis - CARBOMEDICS™ - Corcym - titanium - image - 3
Aortic valve prosthesis - CARBOMEDICS™ - Corcym - titanium - image - 4
Aortic valve prosthesis - CARBOMEDICS™ - Corcym - titanium - image - 5
Add to favorites
Compare this product
 

Characteristics

Valve type
aortic
Material
titanium

Description

Tailored options for desirable Patient outcomes 1 With its CarbomedicsTM line of products CORCYM offers Cardiac Surgeons and Patients a complete set of mechanical heart valve solutions to reliably treat even the challenging cases2 Since the first step, the Carbomedics portfolio has been enriched over time up to the current, complete set of solutions that offer surgeons flexibility while treating their Patients Available Aortic Models CARBOMEDICS TOP HAT Totally Supra-Annular Aortic Valve Sizes 19-27 mm CARBOMEDICS STANDARD Aortic Valve Sizes 19-31 mm * *Small sizes also available CARBOMEDICS REDUCED Aortic Valve Sizes 19-29 mm Tailored safety and durability1 The Carbomedics name is intrinsically linked to the historical development of mechanical heart valves. Based on the expertise and with the clear mission of providing highly reliable and technologically advanced solutions, in 1986 Carbomedics introduced to the market a mechanical bileaflet valve with a rotatable housing for optimal leaflet positioning. Thanks to its robust design, the Carbomedics bileaflet mechanical heart valve has extremely low incidence of post-operative structural failures* in over 1 million implants worldwide. A robust design** to minimize post-operative structural failures. Pyrolytic carbon coated leaflets Pyrolytic carbon housing Titanium stiffening band *Based on Corcym post-market surveillance, structural valve failure is expected to occur between 0.1 and 1 times per 100000 device population. **According to ISO 5840, CORCYM post-market surveillance and published experience on long term results (Bouchard et al., Ann Thorac Surg2014;97:816–23).
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.